Showing 141 - 160 results of 173 for search 'active crohn’s disease.', query time: 0.08s Refine Results
  1. 141

    The role of adhesion molecules in inflammatory bowel disease in children. Assessment of the possible risk of cardiovascular complications by Aneta Trzeciak-Jędrzejczyk, Ryszard Makosiej, Michał Kolejwa, Ewa Głowacka, Elżbieta Czkwianianc

    Published 2017-09-01
    “…Material and methods : The study included 40 patients with IBD (25 with Crohn’s disease – CD and 15 with ulcerative colitis – UC) aged 4–17 years. …”
    Get full text
    Article
  2. 142

    Interleukin-10 in the Pathophysiology of Inflammatory Bowel Disease: Increased Serum Concentrations During the Recovery Phase by Keiichi Mitsuyama, Nobuo Tomiyasu, Kosuke Takaki, Junya Masuda, Hiroshi Yamasaki, Kotaro Kuwaki, Teiko Takeda, Shigehiko Kitazaki, Osamu Tsuruta, Michio Sata

    Published 2006-01-01
    “…Using a specific enzyme-linked immunosorbent assay, IL-10 concentrations were measured in serum from 62 patients with ulcerative colitis (UC), 43 with Crohn's disease (CD), 25 with other colitides, and 44 normal control subjects. …”
    Get full text
    Article
  3. 143

    Alternations of the gut microbiota and the Firmicutes/Bacteroidetes ratio after biologic treatment in inflammatory bowel disease by Yu-Chieh Tsai, Wei-Chen Tai, Chih-Ming Liang, Cheng-Kun Wu, Ming-Chao Tsai, Wan-Hsiang Hu, Pao-Yuan Huang, Chien-Hung Chen, Yuan-Hung Kuo, Chih-Chien Yao, Seng-Kee Chuah

    Published 2025-02-01
    “…Background: The inflammatory bowel disease (IBD), comprising Crohn's disease (CD) and ulcerative colitis (UC) is a complex disease with multifactorial etiology. …”
    Get full text
    Article
  4. 144

    Natural Killer Cell and Large Granular Lymphocyte Deficiency in the Gut of Children with Inflammatory Bowel Disease by F Hadziselimovic, LR Emmons, U Schaub

    Published 1990-01-01
    “…The authors also present a new therapeutic strategy consisting of low dose interferon-alpha-2a that is efficacious in ameliorating ulcerative col iris and Crohn's disease and concomitantly increasing the number of natural killer cells and LGL in the gut.…”
    Get full text
    Article
  5. 145

    High Intestinal and Systemic Levels of Interleukin-23/T-Helper 17 Pathway in Chinese Patients with Inflammatory Bowel Disease by Lu Song, Rui Zhou, Sha Huang, Feng Zhou, Shufang Xu, Wei Wang, Fengming Yi, Xiaobing Wang, Bing Xia

    Published 2013-01-01
    “…Additionally, the mRNA and protein expression of JAK2 and IL-23R were increased in UC and Crohn’s disease (CD) patients. Taken together, our results provided evidence that IL-23/Th17 pathway genes may represent important biomarkers of active stage of IBD and serve as novel therapeutic targets for IBD in Chinese population.…”
    Get full text
    Article
  6. 146

    Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease by Tetsuhiro Yoshimura, Keiichi Mitsuyama, Ryosuke Sakemi, Hidetoshi Takedatsu, Shinichiro Yoshioka, Kotaro Kuwaki, Atsushi Mori, Shuhei Fukunaga, Toshihiro Araki, Masaru Morita, Kozo Tsuruta, Hiroshi Yamasaki, Takuji Torimura

    Published 2021-01-01
    “…Studies on serum leucine-rich alpha-2 glycoprotein (LRG) in inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), are scarce; the methods for estimating disease activity are less established, particularly for CD. …”
    Get full text
    Article
  7. 147

    Reduction of depressive symptoms among patients with inflammatory bowel disease treated with biological therapy: a quantitative comparative incision study by J. Zinkevičiūtė, S. Ambrasas, A. Kiziela, R. Strumila, S. Brašiškienė, E. Dlugauskas

    Published 2019-06-01
    “…Patients diagnosed with active ulcerative colitis or Crohn’s disease and not using antidepressants were included in the study. …”
    Get full text
    Article
  8. 148

    Anti-TNF-α Monoclonal Antibody Therapy Improves Anemia through Downregulating Hepatocyte Hepcidin Expression in Inflammatory Bowel Disease by Weigang Shu, Zhi Pang, Chunjin Xu, Jian Lin, Gengfeng Li, Wei Wu, Suofeng Sun, Junxiang Li, Xiuling Li, Zhanju Liu

    Published 2019-01-01
    “…We observed that the levels of serum hepcidin were increased in active IBD patients compared with those in remitted IBD patients and healthy controls and that serum hepcidin was associated with disease activity, CRP, and ESR, respectively. …”
    Get full text
    Article
  9. 149
  10. 150
  11. 151

    Protocol for a first-in-human feasibility study of T regulatory cells (TR004) for inflammatory bowel disease using (ex vivo) Treg expansion (TRIBUTE) by Jennifer Clough, Peter Irving, A Toby Prevost, Graham M Lord, Joana Vasconcelos, James B Canavan, Beverley Rodger, D Macallan

    Published 2025-01-01
    “…Introduction Crohn’s disease (CD) is a chronic, immune-mediated inflammatory bowel disease (IBD), presenting with symptoms of abdominal pain and bleeding from the gastrointestinal tract. …”
    Get full text
    Article
  12. 152

    Self-reported food intolerance, dietary supplement use and malnutrition in chronic inflammatory bowel diseases: Findings from a cross-sectional study in Lebanon. by Maha Hoteit, Nour Ftouni, Malak Olayan, Souheil Hallit, Joya Maria Karam, Mahmoud Hallal, Samer Hotayt, Bilal Hotayt

    Published 2024-01-01
    “…<h4>Background/aims</h4>Chronic inflammatory bowel diseases (IBDs), including Crohn's disease and ulcerative colitis are known for a combination of food intolerance, decreased oral intake, and malabsorption which all predispose patients to malnutrition and suboptimal dietary intake. …”
    Get full text
    Article
  13. 153

    Phenotypes of primary sclerosing cholangitis in children by M.B. Dyba, V.S. Berezenko

    Published 2024-12-01
    “…Small duct involvement alone was present in 26 % of cases, with cirrhosis in 12.5 % (p = 0.01). Inflammatory bowel disease (IBD) was diagnosed in 84 % of children with PSC: 32 % had ulcerative colitis, 38 % had indeterminate IBD, and 16 % had Crohn’s disease. …”
    Get full text
    Article
  14. 154

    Real-World Evidence of Clinical Outcomes of the Use of the Adalimumab Biosimilar SB5 in Rheumatic and Gastrointestinal Immune-Mediated Inflammatory Diseases: 12-Month Data from the... by Bruno Fautrel, Yoram Bouhnik, Carine Salliot, Franck Carbonnel, Mathurin Fumery, Christophe Bernardeau, Yves Maugars, Mathurin Flamant, Fabienne Coury, Ben Braithwaite, Salima Hateb, Janet Addison, the PERFUSE investigators

    Published 2024-10-01
    “…Clinical data, including disease activity scores, C-reactive protein levels, and dosing information, were collected as available from patient records captured during routine visits to specialist physicians. …”
    Get full text
    Article
  15. 155

    The Safety of Infliximab Infusions in the Community Setting by James Ducharme, Cindy Pelletier, Ramesh Zacharias

    Published 2010-01-01
    “…BACKGROUND: Tumour necrosis factor-alpha (TNFα) has an important role in the pathogenesis of inflammatory conditions such as rheumatoid arthritis, Crohn’s disease, ulcerative colitis and psoriasis. …”
    Get full text
    Article
  16. 156

    Certolizumab pegol in severe hidradenitis suppurativa in pregnancy: A case report by Paolo Gisondi, Elena Montalto, Tea Curic, Elisabetta Danese, Francesco Bellinato, Giampiero Girolomoni

    Published 2025-01-01
    “…Certolizumab pegol is a pegylated monoclonal TNF-α inhibitor that lacks the fragment crystallizable region preventing active placental transfer and could be used in pregnancy and lactation if clinically needed and is label for chronic plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease. …”
    Get full text
    Article
  17. 157

    Histopathology of Infectious Colitis by Christina M. Surawicz

    Published 1989-01-01
    “…Granulomas usually indicate Crohn's disease but can he seen with infections due to Chlamydia trachomatis, Treponema pallidum and Mycobacterium tuberculosis. …”
    Get full text
    Article
  18. 158

    Ingestible Wireless Capsule Technology: A Review of Development and Future Indication by M. R. Basar, F. Malek, Khairudi M. Juni, M. Shaharom Idris, M. Iskandar M. Saleh

    Published 2012-01-01
    “…Ingestible wireless capsule endoscopy (WCE) is the one and only painless, effective, novel, diagnostic technology for inspecting the entire gastrointestinal (GI) tract for various diseases, such as obscure gastrointestinal bleeding (OGIB), tumors, cancer, Crohn’s disease, and celiac disease. …”
    Get full text
    Article
  19. 159

    Preventive Effect of TU-100 on a Type-2 Model of Colitis in Mice: Possible Involvement of Enhancing Adrenomedullin in Intestinal Epithelial Cells by Atsushi Kaneko, Toru Kono, Naoko Miura, Naoko Tsuchiya, Masahiro Yamamoto

    Published 2013-01-01
    “…Purpose. Crohn's disease (CD) and ulcerative colitis (UC), the two major forms of inflammatory bowel disease (IBD), have histopathologically and immunologically different characteristics. …”
    Get full text
    Article
  20. 160

    The Pivotal Role of TBK1 in Inflammatory Responses Mediated by Macrophages by Tao Yu, Young-Su Yi, Yanyan Yang, Jueun Oh, Deok Jeong, Jae Youl Cho

    Published 2012-01-01
    “…Inflammation is considered to be a major cause of most chronic diseases, especially in more than 100 types of inflammatory diseases which include Alzheimer's disease, rheumatoid arthritis, asthma, atherosclerosis, Crohn's disease, colitis, dermatitis, hepatitis, and Parkinson's disease. …”
    Get full text
    Article